Oncology & Cancer
Breakthrough drug shows early promise for multiple myeloma
A small clinical trial has shown that a new drug has promise for targeting tumours in patients with an aggressive type of blood cancer.
Oct 8, 2018
0
26
Page 9 - News tagged with myeloma cells
Oncology & Cancer
Multiple myeloma: A bold study to make allografting safer and more efficient
In a 10-patient cohort study led by Dr. Jean Roy, hematologist and professor at the Faculty of Medicine of Université de Montréal, that aims to understand how to mitigate the risks associated with the treatment of multiple ...
May 11, 2018
0
3
Oncology & Cancer
Multiple sclerosis drug could reduce painful side effects of common cancer treatment
Researchers from the Saint Louis University School of Medicine have discovered why many multiple myeloma patients experience severe pain when treated with the anticancer drug bortezomib. The study, which will be published ...
Apr 27, 2018
0
133
Oncology & Cancer
Tumor imaging technique has potential as anti-cancer weapon, mouse study shows
A new anti-cancer strategy wields light as a precision weapon. Unlike traditional light therapy—which is limited to the skin and areas accessible with an endoscope—this technique can target and attack cancer cells that ...
Jan 26, 2018
0
230
Oncology & Cancer
In multiple myeloma, high levels of enzyme ADAR1 are associated with reduced survival
Multiple myeloma is the second most common blood cancer in the United States. Thirty to 50 percent of multiple myeloma patients have extra copies of the gene that encodes the enzyme ADAR1. Using a database of multiple myeloma ...
Dec 5, 2017
0
2
Oncology & Cancer
Anti-myeloma agent opens for new treatment strategy
The tumour form multiple myeloma is very challenging to treat and is still considered incurable. In a recently published study in the scientific journal Oncotarget, researchers at Uppsala University show how inhibition of ...
Oct 27, 2017
0
1
Oncology & Cancer
Test results after stem cell transplant for multiple myeloma can confuse patients and doctors about
It's a cancer of the plasma cells, which normally make an array of antibodies that protect us from infection.
Aug 10, 2017
0
1
Oncology & Cancer
CAR T-Cell therapy sends multiple myeloma into lasting remission
In an early clinical trial, 33 out of 35 (94%) patients had clinical remission of multiple myeloma upon receiving a new type of immunotherapy ? chimeric antigen receptor (CAR) T cells targeting B-cell maturation protein or ...
Jun 5, 2017
0
2
Oncology & Cancer
Scientists give tumor-fighting cells a boost in battling bone marrow cancer
Researchers from Belgium led by Prof. Dirk Elewaut of the VIB-UGent Center for Inflammation Research and the team of Prof. Vanderkerken and Prof. Menu at the Hematology and Immunology lab of the VUB uncovered a new way to ...
Jun 1, 2017
0
0
Oncology & Cancer
Researchers identify therapy that shrinks tumors in patients with multiple myeloma
Mayo Clinic researchers have found that an experimental drug, LCL161, stimulates the immune system, leading to tumor shrinkage in patients affected by multiple myeloma. The findings are published in Nature Medicine.
Mar 8, 2017
0
2
